Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-31 @ 1:19 AM
Study NCT ID:
NCT06762769
Status:
RECRUITING
Last Update Posted:
2025-08-01
First Post:
2024-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Sponsor:
University College, London
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2032-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-11
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-09
First Submit QC Date:
None
Study First Post Date:
2025-01-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-29
Last Update Post Date:
2025-08-01
Last Update Post Date Type:
ACTUAL